These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21997726)

  • 1. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States.
    Bhattacharyya N
    Laryngoscope; 2011 Sep; 121(9):1830-3. PubMed ID: 21997726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Incremental Healthcare Costs for Chronic Rhinosinusitis in the United States.
    Bhattacharyya N
    Laryngoscope; 2021 Oct; 131(10):2169-2172. PubMed ID: 33606274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental direct expenditure of treating asthma in the United States.
    Kamble S; Bharmal M
    J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States.
    Bhattacharyya N
    Ann Otol Rhinol Laryngol; 2011 Jul; 120(7):423-7. PubMed ID: 21859049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Incremental Healthcare Costs for Allergic Rhinitis in the United States.
    Workman AD; Dattilo L; Rathi VK; Bhattacharyya N
    Laryngoscope; 2022 Aug; 132(8):1510-1514. PubMed ID: 34473353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment.
    Hay J; Jhaveri M; Tangirala M; Kaliner M
    Allergy Asthma Proc; 2009; 30(6):634-42. PubMed ID: 20031009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic consequences of comorbid depression, anxiety, and allergic rhinitis.
    Cuffel B; Wamboldt M; Borish L; Kennedy S; Crystal-Peters J
    Psychosomatics; 1999; 40(6):491-6. PubMed ID: 10581977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allergic rhinitis--an epidemiological, economical and social problem of the XXI century].
    Rutkowski R; Kosztyła-Hojna B; Rutkowska J
    Pneumonol Alergol Pol; 2008; 76(5):348-52. PubMed ID: 19003765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender disparities in medical expenditures attributable to hypertension in the United States.
    Basu R; Franzini L; Krueger PM; Lairson DR
    Womens Health Issues; 2010; 20(2):114-25. PubMed ID: 20211429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
    Balu S
    Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study.
    Hankin CS; Cox L; Lang D; Bronstone A; Fass P; Leatherman B; Wang Z
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):79-85. PubMed ID: 20143650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of obesity on health service utilization and costs in childhood.
    Trasande L; Chatterjee S
    Obesity (Silver Spring); 2009 Sep; 17(9):1749-54. PubMed ID: 19300433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and utilization impacts of oral antihistamines in the California Medi-Cal program.
    Hay JW; Leahy M
    Value Health; 2005; 8(4):506-16. PubMed ID: 16091028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory care visits for asthma: United States, 1993-94.
    Burt CW; Knapp DE
    Adv Data; 1996 Sep; (277):1. PubMed ID: 10166755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report on health care for children and youth in the United States: focus on injury-related emergency department utilization and expenditures.
    Owens PL; Zodet MW; Berdahl T; Dougherty D; McCormick MC; Simpson LA
    Ambul Pediatr; 2008; 8(4):219-240.e17. PubMed ID: 18644545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study.
    Magnan A; Meunier JP; Saugnac C; Gasteau J; Neukirch F
    Allergy; 2008 Mar; 63(3):292-8. PubMed ID: 18028246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of allergic rhinitis in Korea.
    Kim SY; Yoon SJ; Jo MW; Kim EJ; Kim HJ; Oh IH
    Am J Rhinol Allergy; 2010; 24(5):e110-3. PubMed ID: 21244726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.